Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > leedejones viewpoint...not Salley's though

<< Previous

Bullboard Posts

Next >>

Comment by steadfaston Aug 08, 2021 11:05pm

132 Views

Post# 33670451

RE:RE:leedejones viewpoint...not Salley's though

I just received this report 10 minutes ago from an Investor. It is dated June 29th, one day
prior to AGM. SVA should have emailed this report to every Investor on June 29th so we
would have had it for AGM. It would have been a good Public Relations gesture, just using
good common sense. I am absolutely furious that I am seeing it for the 1st time -
6 weeks after publishing. Time somebody starts Cracking the Whip. This is inexcusable.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta